From Our Partners
Thursday, June 23, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Developing a Next Generation Q Fever Vaccine

by Global Biodefense Staff
January 21, 2015
Q Fever Coxiella burnetii bacteria

A recent review published in the journal Frontiers in Microbiology highlights key aspects of Q Fever, discussing the risk the disease poses to military personnel, recent advances in countermeasures and a strategic approach to provide a next-generation vaccine against Q Fever for the warfighter.

Q Fever represent a threat due to its low infectious dose and environmental stability. The causative agent, Coxiella burnetii, is found worldwide and can be spread via inhalational exposure to the bacteria.

While considered a potential bioterroism agent, the military is also concerned about natural exposures to Q Fever. In an analysis of U.S. troops deployed to an area of Iraq with known Q Fever outbreaks, 7.2 percent were suspected to have been naturally exposed to C. burnetii during the deployment.

In a more comprehensive study, deployed warfighters admitted to hospitals with fever and other non-specific symptoms were monitored to determine which pathogens may have caused the illness. Approximately 10 percent of these individuals tested positive for Q Fever.

As chronic cases of Q Fever are difficult to diagnose and treat with antibiotics, vaccination strategies have been considered a viable alternative for at-risk populations. Q-Vax is a formalin-inactivated whole cell vaccine that is currently being utilized in Australia, demonstrating that effective, vaccine-mediated protection is possible. However, this vaccine cannot be administered to individuals that have previously been exposed to C. burnetii, which can represent a large percentage of deployed forces.

Given such limitations, the Department of Defense desires a next-generation vaccine against Q Fever that could be administered to the warfighter regardless of their exposure history.

Read more at Frontiers in Microbiology:  Vaccination against Q fever for biodefense and public health indications

Source: DTRA, adapted.

From Our Partners
Tags: Q FeverVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America
Infectious Diseases

Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America

June 10, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC